Trial Profile
A trial to study the effect of botulinum toxin A in severe diabetic neuropathies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- 02 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology